Table 2.
Clinical characteristics of patients with T2DM by TG category.
Normal TG group (≤1.7 mmol/L) |
Hypertriglyceridemic group (>1.7 mmol/L) | P value | |
---|---|---|---|
n | 46 | 33 | |
Gender (F, %) | 18 (39.1%) | 17 (51.5%) | 0.274 |
Age (years) | 55.7 ± 10.2 | 55.4 ± 10.0 | 0.914 |
DM course (years) | |||
0-1 | 14 (30.4%) | 6 (18.2%) | |
1-10 | 19 (41.3%) | 16 (48.5%) | 0.466 |
>10 | 13 (28.3%) | 11 (33.3) | |
History of DM | 14 (30.4%) | 12 (36.4%) | 0.580 |
Hypertension | 16 (34.8%) | 20 (60.6%) | 0.023 |
Gastrointestinal disorders | 5 (10.9%) | 5 (15.2%) | 0.734 |
Smoking | 14 (30.4%) | 12 (36.4%) | 0.580 |
Drinking | 14 (30.4%) | 11 (33.3%) | 0.785 |
BMI (kg/m2) | 25.2 ± 2.9 | 26.8 ± 2.7 | 0.017 |
HbA1c (%) | 9.0 ± 2.4 | 9.2 ± 1.9 | 0.801 |
TC (mmol/L) | 4.40 ± 0.95 | 5.01 ± 1.18 | 0.014 |
HDL-C (mmol/L) | 1.08 ± 0.22 | 1.03 ± 022 | 0.321 |
LDL-C (mmol/L) | 2.89 ± 0.72 | 3.31 ± 0.73 | 0.015 |
VLDL-C (mmol/L) | 0.39 (0.24) | 0.65 (0.43) | 0.000 |
ApoA1 (mmol/L) | 1.26 ± 0.18 | 1.33 ± 0.21 | 0.158 |
ApoB (mmol/L) | 0.75 ± 0.17 | 0.90 ± 0.23 | 0.002 |
Total protein (g/L) | 67.13 ± 5.74 | 69.78 ± 6.28 | 0.056 |
Albumin (g/L) | 41.28 ± 2.61 | 41.19 ± 2.40 | 0.877 |
BUN (mmol/L) | 5.22 ± 1.29 | 4.81 ± 1.25 | 0.158 |
Cr (μmmol/L) | 68.42 ± 11.97 | 69.65 ± 13.95 | 0.682 |
25OHD (ng/mL) | 16.73 (9.72) | 13.61 (7.01) | 0.120 |
OC (ng/mL) | 15.55 ± 4.85 | 12.97 ± 4.54 | 0.020 |
β-CTX (ng/mL) | 0.49 (0.32) | 0.32 (0.24) | 0.007 |
P1NP (ng/mL) | 47.32 (25.95) | 34.79 (20.77) | 0.007 |
PTH (pg/mL) | 40.81 ± 13.22 | 42.03 ± 16.15 | 0.714 |
OP | 26 (56.5%) | 9 (27.3%) | 0.010 |
Note: data were expressed as number (%) or mean ± SD/median (interquartile range). Abbreviations: ApoA1: apolipoprotein A1; ApoB: apolipoprotein B; BMD: bone mineral density; BMI: body mass index; BUN: blood urea nitrogen; Cr: creatinine; DM: diabetes mellitus; HbA1c: glycated hemoglobin; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; T2DM: type 2 diabetes mellitus; TC: total cholesterol; TG: triglyceride; VLDL-C: very-low-density lipoprotein cholesterol; OC: osteocalcin; OP: osteoporosis; P1NP: procollagen type 1 N-terminal propeptide; PTH: parathyroid hormone; 25OHD: 25-hydroxyvitamin D; β-CTX: β-C-terminal cross-linked telopeptide of type I collagen.